BayFirst Restates 2024-2025 Financials, Discloses Material Weakness and Clawbacks
BAFN sits 47% above its 52-week low of $4.259 on elevated volume (1.8× avg).
Summary
BayFirst's amended 10-K quantifies the restatement: 2024 net income cut to $10.2M, 2025 loss widened to $24.6M, plus a material weakness and executive clawbacks.
Key Events · Legal and Risk Events · BAFN
-
Restated Financials Quantified
2024 net income reduced by $2.4 million to $10.2 million; 2025 net loss widened by $1.6 million to $24.6 million, driven by understated credit losses and overstated gain-on-sale.
-
Material Weakness Disclosed
Management identified a material weakness in internal control over financial reporting related to nonaccrual loan processing and gain-on-sale calculations, concluding controls were ineffective as of December 31, 2025.
-
Executive Clawbacks
The company determined $316,946 in erroneously awarded incentive compensation must be recovered from four current and former executive officers.
-
Preferred Stock Redemption
On August 10, 2026, BayFirst paid $9.7 million to redeem all outstanding Series A and Series B preferred shares, including accrued dividends.
Analysis · BAFN · Finance
The 10-K/A formalizes the restatement first announced on July 15, 2026, with audited numbers: 2024 net income falls $2.4 million to $10.2 million, and 2025's net loss widens $1.6 million to $24.6 million. The filing also reveals a material weakness in internal controls over loan nonaccrual and gain-on-sale accounting, and it discloses $316,946 in incentive compensation to be clawed back from four executives. These are governance red flags that deepen the credibility crisis already signaled by the asset resolution plan and prior restatement news.
At the time of this filing, BAFN was trading at $6.28 on NASDAQ in the Finance sector, with a market capitalization of approximately $25.8M. The 52-week trading range was $4.26 to $11.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.